Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 154, Issue 5, 1996, Pages 1426-1429

  Kirchner, Kevin K ^a   Wagener, Jeff S ^a,b   Khan, Talat Z ^a   Copenhaver, Steven C ^a   Accurso, Frank J ^a  

^a Children's Hospital Colorado   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; DNA CONTENT; HUMAN; INFANT; LEUKOCYTE COUNT; LUNG LAVAGE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0029799340     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.154.5.8912759     Document Type: Article

References (16)

1. FitzSimmons, S. C. 1993. The changing epidemiology of cystic fibrosis. J. Pediatr. 122:1-9.
2. Fick, R. B. 1989. Pathogenesis of the pseudomonas lung lesion in cystic fibrosis. Chest 96:158-164.
3. Shak, S., D. J. Capon, R. Hellmiss, S. A. Marsters, and C. L. Baker. 1990. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Pro. Natl. Acad. Sci. U.S.A. 87:9188-9192.
4. Fuchs, H. J., D. S. Borowitz, D. H. Christiansen, E. M. Morris, M. L. Nash, B. L. Ramsey, B. J. Rosenstein, A. L. Smith, and M. E. Wohl for the Pulmozyme Study Group. 1994. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. N. Engl. J. Med. 331:637-642.
5. Hammond, K. B., S. H. Abman, R. J. Sokol, and F. J. Accurso. 1991. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N. Engl. J. Med. 325:769-774.
6. Brasfield, D., G. Hicks, S. Soong, and R. E. Tiller. 1979. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 63: 24-29.
7. Labarca, C., and K. Paigen. 1980. A simple, rapid, and sensitive DNA assay procedure. Anal. Biochem. 102:344-352.
8. Lethem, M. I., S. L. James, C. Marriott, and J. F. Burke. 1990. The origin of DNA associated with mucus glycoproteins in cystic fibrosis sputum. Eur. Respir. J. 3:19-23.
9. Statview V1.02 5/10/88. Abacus Concepts, Inc., Berkeley, CA.
10. Rosner, B. 1986. Fundamentals of Biostatistics, 2nd ed. Duxbury Press, Boston. 467-472.
11. Fahy, J. V., D. J. Steiger, J. Lice, C. B. Basbaum, W. E. Finkbeiner, and H. A. Boushey. 1993. Markers of mucus secretion and DNA levels in induced sputum from asthmatics and from healthy subjects. Am. Rev. Respir. Dis. 147:1132-1137.
12. Khan, T. Z., J. S. Wagener, T. Bost, J. Martinez, F. J. Accurso, and D. W. H. Riches. 1995. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1075-1082.
13. Wilmott, R. W., J. T. Kassab, P. L. Kilian, W. R. Benjamin, S. D. Douglas, and R. E. Wood. 1990. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am. Rev. Respir. Dis. 142:365-368.
14. Birrer, P., N. G. McElvaney, A. Rudeberg, C. Wirz Sommer, S. Liechti-Gallati, R. Kraemer, R. Hubbard, and R. G. Crystal. 1994. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150:207-213.
15. Konstan, M. W., K. A. Milliard, T. M. Norvell, and M. Berger. 1994. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am. J. Respir. Crit. Care Med. 150:448-454.
16. Cantin, A. 1995. Cystic fibrosis lung inflammation: early, sustained, and severe. Am. J. Respir. Crit. Care Med. 151:939-941.